SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-007143
Filing Date
2024-02-20
Accepted
2024-02-20 09:37:27
Documents
19
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 62481
2 ex10-1.htm EX-10.1 458061
3 ex10-2.htm EX-10.2 59052
4 ex99-1.htm EX-99.1 17117
5 ex99-2.htm EX-99.2 18471
  Complete submission text file 0001493152-24-007143.txt   929499

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20240213.xsd EX-101.SCH 3976
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20240213_def.xml EX-101.DEF 27432
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20240213_lab.xml EX-101.LAB 37886
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20240213_pre.xml EX-101.PRE 26049
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6761
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24651203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)